Reuters logo
BRIEF-Adaptimmune announces initiation of study to evaluate SPEAR T-cell therapy
2017年5月10日 / 中午11点45分 / 6 个月前

BRIEF-Adaptimmune announces initiation of study to evaluate SPEAR T-cell therapy

May 10 (Reuters) - Adaptimmune Therapeutics Plc

* Adaptimmune announces initiation of study to evaluate SPEAR T-cell therapy targeting AFP in liver cancer Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below